Xiidra is a drug specifically used to treat dry eye disease (DED). Dry eye disease is a common eye disease characterized by insufficient or poor quality tears, which leads to eye discomfort, pain and visual impairment. Xiidra helps relieve these symptoms and improve the quality of life of patients through its unique mechanism.
What is Xiidra?
Xiidra is a drug specifically used to treat dry eye disease (DED). It belongs to the category of lymphocyte function-associated antigen-1 (LFA-1) antagonists. Its working principle is to inhibit the binding of LFA-1 to intercellular adhesion molecule 1 (ICAM-1), thereby reducing the level of inflammation mediated by T lymphocytes. This anti-inflammatory effect helps to reduce eye damage caused by dry eye disease and relieve the patient's discomfort.
In clinical studies, Xiidra showed a more significant therapeutic effect. Compared with other drugs for the treatment of dry eye disease, Xiidra has more advantages in alleviating the condition.
Before using Lifitegrast, patients should consult a doctor in detail to understand the indications, contraindications, side effects and precautions of the drug. Patients should also follow the doctor's advice and use the drug according to the prescribed dosage and usage to achieve the best therapeutic effect.
What are the precautions when using Lifitegrast?
When using Lifitegrast, patients need to pay attention to the following matters.
Follow the doctor's instructions and prescriptions
The dosage and frequency of Lifitegrast should be strictly followed according to the doctor's advice and should not be increased or decreased at will. The doctor will develop a personalized treatment plan based on the patient's specific condition and needs, and the patient should strictly follow it.
Allergic patients are prohibited from using it
Patients who are known to be allergic to Lifitegrast or any other ingredients in the formula should avoid using this drug. Allergic reactions may include severe symptoms such as eye irritation, redness, swelling, and itching. Allergic patients should not use Lifitegrast.
Pregnant and lactating women
Pregnant and lactating women should consult a doctor before using Lifitegrast. Currently, there are limited studies on the safety of using Lifitegrast for these two groups of people. Patients need to weigh the pros and cons and make decisions under the guidance of a doctor.
When using Lifitegrast, patients should follow the doctor's instructions, pay attention to allergic risks, drug interactions and changes in eye conditions, and purchase and use drugs through formal channels. Through reasonable medication, patients can effectively relieve the symptoms of dry eye and improve their quality of life.
